🇺🇸 PF-08065010 in United States

PF-08065010 (pf-08065010) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

PF-08065010 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is PF-08065010 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for PF-08065010 in United States?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.